Navigation Links
Private Healthcare Facilities Strengthen Cardiac Patient Monitoring Devices Market in CEE, Finds Frost & Sullivan
Date:12/5/2012

LONDON, Dec. 5, 2012 /PRNewswire/ -- The rising incidence of cardiovascular diseases is increasing the focus of healthcare providers, payers and patients on early diagnosis and prevention. At the same time, the cardiac patient monitoring market in Central and Eastern Europe (CEE) is saturating, and the products themselves are becoming commoditised.

"Nevertheless, the dynamic development of private healthcare facilities in CEE countries is expected to drive the expansion of installed base of cardiac patient monitoring devices," notes Frost & Sullivan Industry Analyst Dominika Grzywinska. "This, in turn, should postpone progressing market saturation."

New analysis from Frost & Sullivan (http://www.healthcare.frost.com), Central and Eastern European Cardiac Patient Monitoring Market Outlook, finds that the market earned revenues $63.3 million in 2011 and estimates this to reach $83.9 million in 2016. The research covers resting electrocardiogram (ECG), stress ECG, cardiac event recorders, ECG Holter monitors and data management systems (DMS) segments across Bulgaria, the Czech Republic, Hungary, Poland and Romania.

Cardiac patient monitoring devices, especially resting ECG units, are becoming a commodity in the CEE healthcare space. Most healthcare facilities are equipped with such devices, which has resulted in impending market saturation.

This trend is further intensified by limited changes in the technology development arena. With no new solutions that add significant clinical value being launched, the installed base has less growth potential. However, the dynamic development of private healthcare facilities, especially in Bulgaria, Poland and Romania, is generating sizeable demand for new cardiac patient monitoring units.

End user price sensitivity remains a concern. While factors like quality or service are also considered, price is often the main criterion in product selection.

"This explains the success of Asian vendors in the CEE market who offer similar quality devices, albeit at more attractive prices," explains Grzywinska. "Combined with looming market saturation, the situation is expected to lead to price erosion and decreasing vendor profitability."

In order to maintain profitability, vendors should not only maintain competitive product pricing, but also look for alternative ways of attracting customers. Such strategies could include introducing value-added offerings, rapid and reliable maintenance services or designing comprehensive package solutions, including DMS.

If you are interested in more information on this study, please send an email with your contact details to Anna Zanchi, Corporate Communications, at anna.zanchi@frost.com.

Central and Eastern European Cardiac Patient Monitoring Market Outlook is part of the Advanced Medical Technologies Growth Partnership Service programme, which also includes research in the following markets: European Cardiac Patient Monitoring Solutions, Emerging Technologies in Cardiac Monitoring and, European Remote Patient Monitoring Market. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organisation prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion
Join Us:           Join our community
Subscribe:       Newsletter on "the next big thing"
Register:         Gain access to visionary innovation

 

Contact
Anna Zanchi
Corporate Communications – Europe
P: +39.02.4851 6133
E: anna.zanchi@frost.com
http://www.frost.com


'/>"/>
SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. FDA, Medical Device Industry and NORD Announce New Public-Private Partnership
2. Trovagene Announces Closing of Private Placement of $3.76 Million from the Sale of Restricted Common Stock and Warrants
3. Sarnova Launches Curaplex Private Label Brand
4. Novelos Therapeutics Closes $2 Million Private Placement
5. MEI Pharma Announces $27.5 Million Private Placement
6. Access Pharmaceuticals Announces Private Placement Financing
7. Valeant Pharmaceuticals International, Inc. Announces Pricing Of Concurrent Private Offerings Of Senior Notes
8. Valeant Pharmaceuticals Announces Launch of Concurrent Private Offerings of Senior Notes
9. 3SBio Independent Committee Selects Legal Counsel in connection with Going Private Proposal
10. 3SBio Inc. Announces Receipt of "Going Private" Proposal at $15 Per ADS
11. Millennium Surgical Corp. Named to Inc. 5000 List of Fastest Growing Private Companies for The Second Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
(Date:6/23/2016)... RIDGE, Ill. and INDIANAPOLIS ... of students receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship ... The 2016 scholarship winners, announced today online at ... to let type 1 diabetes stand in the way ... Diabetes has supported the Foundation,s scholarship program since 2012, ...
(Date:6/23/2016)... 2016 The vast majority of dialysis patients ... Treatments are usually 3 times a week, with treatment ... travel time, equipment preparation and wait time.  This regimen ... for patients who are elderly and frail.  Many elderly ... rehabilitation centers for some duration of time. ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to ... of individuals in the United States and Canada wear eyeglasses. Once considered to be ... vision and make a fashion statement. Even celebrities use glasses as a way of ...
(Date:6/26/2016)... Viejo, California (PRWEB) , ... June 26, 2016 , ... ... Final Cut Pro X. , "Film editors can give their videos a whole new ... said Christina Austin - CEO of Pixel Film Studios. , ProSlice Levels contains ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women ... diagnosed with endometriosis. These women need a treatment plan to not only alleviate ... that can help for preservation of fertility and ultimately achieving a pregnancy. The ...
(Date:6/25/2016)... ... ... The temporary closing of Bruton Memorial Library on June 21 due to a possible lice ... overlooked aspect of head lice: the parasite’s ability to live away from a human host, ... a necessary one in the event that lice have simply gotten out of control. , ...
(Date:6/25/2016)... CA (PRWEB) , ... June 25, 2016 , ... As ... with Magna Cum Laude and his M.D from the David Geffen School of Medicine ... and returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive ...
Breaking Medicine News(10 mins):